NIH Locks Doors on Biotech Grant Review Sessions
Published Date: 3/16/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings on April 14, 2026, to review and decide on important grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for cool science projects. If you’re involved in bioengineering, AI, or biotech grants, these reviews could impact your funding and research timeline.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Closed NIH Grant Review Meetings
The NIH Center for Scientific Review will hold several closed virtual meetings on April 14 and April 15, 2026 to review and evaluate grant applications for listed study sections (for example: Bioengineering Sciences & Technologies; Artificial Intelligence and Technology Collaboratory; Resource Grants in Biotechnology; Clinical Management; Pulmonary Injury, Repair, and Remodeling; HLBS PAR Panel; K Awards; Skeletal Muscle and Rehabilitation Sciences). The meetings are closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property, patentable material, and personal information.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
Previous / Next Documents
Previous: 2026-05069 — Magnuson-Stevens Act Provisions; General Provisions for Domestic Fisheries; Application for Exempted Fishing Permits
Fishing groups want special permission to try new fishing methods that don’t follow some usual rules, all to learn more about cod spawning in the Northeast. This affects federally permitted fishing boats and asks for public comments by March 31, 2026. If approved, it could help improve fishing rules and protect fish, with no immediate cost changes announced.
Next: 2026-05071 — ISO New England Inc.; Notice of Institution of Section 206 Proceeding and Refund Effective Date
The Federal Energy Regulatory Commission is checking if ISO New England’s rules for fixing wrong payments in their energy markets are fair and clear. This could affect anyone who buys or sells energy in New England, with possible refunds starting from March 16, 2026. If you want to speak up, you’ve got 21 days to jump in and share your thoughts!